Equities
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)14.36
  • Today's Change-0.32 / -2.18%
  • Shares traded28.09k
  • 1 Year change-18.04%
  • Beta0.9749
Data delayed at least 15 minutes, as of Nov 15 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Medios AG, formerly Crevalis Capital AG, is a Germany-based company that is active in the pharmacy business. It wholesales, markets, distributes and produces various kinds of goods for pharmacies and other pharmaceutical companies. The Company also provides related services and is engaged in the acquisition and management of other companies from the pharmaceutical industry.

  • Revenue in EUR (TTM)1.84bn
  • Net income in EUR12.88m
  • Incorporated1999
  • Employees1.00k
  • Location
    Medios AGHeidestrasse 9BERLIN 10557GermanyDEU
  • Phone+49 30 232566800
  • Fax+49 30 232566801
  • Websitehttps://medios.ag/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
ILM1X:GER since
announced
Transaction
value
Ceban Pharmaceuticals BVAnnounced19 Mar 202419 Mar 2024Announced3.46%282.65m
Data delayed at least 15 minutes, as of Nov 15 2024 16:35 GMT.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Frontier Biotechnologies Inc17.56m-36.77m368.52m395.00--2.44--20.99-0.7474-0.74740.35693.070.06361.612.72338,416.90-13.31-14.05-16.40-15.7833.622.35-209.43-450.082.02--0.2808--34.82126.637.79--28.13--
Cutia Therapeutics26.14m-68.91m372.85m360.00--2.28--14.27-1.86-1.860.70364.200.12062.316.93718,663.40-31.81---35.82--50.33---263.68--4.82--0.1818--1,110.83---253.30------
Medios AG1.84bn12.88m374.42m1.00k27.560.73789.390.20330.53260.532676.0719.902.3923.1112.283,576,214.001.673.402.364.077.196.050.6991.010.75515.970.31740.0010.8040.342.6234.17-7.11--
Dishman Carbogen Amcis Ltd294.40m-19.57m374.62m1.13k--0.580837.731.27-11.09-11.09166.94365.900.26610.63394.4523,132,690.00-1.77-0.3986-2.21-0.488878.7573.83-6.65-1.540.6001-0.05830.3041--8.414.91-414.93---0.3175--
ASKA Pharmaceutical Holdings Co Ltd386.30m36.32m384.48m762.009.810.91477.590.9953210.94210.942,243.732,263.170.70561.643.8683,419,940.006.634.638.445.8749.3846.949.406.761.71--0.106414.863.946.1278.0334.04-37.8923.36
Enseval Putera Megatrading Tbk PT1.83bn44.07m397.47m5.13k9.030.89847.270.2171271.32271.3211,263.572,727.062.777.157.075,975,601,000.006.647.639.9710.809.8410.712.402.861.53--0.031264.351.716.71-18.761.068.2013.02
Data as of Nov 15 2024. Currency figures normalised to Medios AG's reporting currency: Euro EUR

Institutional shareholders

23.27%Per cent of shares held by top holders
HolderShares% Held
Paladin Asset Management Investmentaktiengesellschaft TGVas of 29 Feb 20241.17m4.57%
SEB Investment Management AB (Denmark)as of 29 Feb 20241.12m4.39%
Allianz Global Investors GmbHas of 29 Jan 2024700.14k2.75%
Norges Bank Investment Managementas of 30 Jun 2024639.40k2.51%
Cr�dit Mutuel Asset Management SAas of 29 Dec 2023494.31k1.94%
Mandatum Life Sijoituspalvelut Oyas of 30 Jun 2024487.87k1.91%
Oddo BHF Asset Management SASas of 30 Aug 2024381.43k1.50%
DNCA Finance SAas of 31 Dec 2023361.03k1.42%
Kreissparkasse Biberachas of 31 Jul 2024293.99k1.15%
Skandinaviska Enskilda Banken AB (Denmark)as of 30 Sep 2024291.14k1.14%
More ▼
Data from 30 Jun 2024 - 31 Oct 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.